Back to Search
Start Over
Dabigatran-induced lupus temporarily preventing blood group determination.
- Source :
-
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2014 Sep; Vol. 25 (6), pp. 625-7. - Publication Year :
- 2014
-
Abstract
- Epistaxis resulted in severe anemia in an 89-year-old Caucasian woman under a therapy with dabigatran for 12 months because of atrial fibrillation. Correction of the anemia was difficult because it was impossible to assess her blood group due to polyagglutination. Since hospital records disclosed that in 2011, her blood group was O positive, acquired polyagglutination was assumed. After 66 days, it was again possible to assess the blood group as O positive. Immunologic investigations disclosed that antinuclear antibodies and antihistone antibodies were elevated, and antibodies to double-stranded DNA were negative. Drug-induced lupus was diagnosed due to the autoantibody profile detected.
- Subjects :
- Aged, 80 and over
Anemia blood
Antibodies, Antinuclear blood
Antithrombins administration & dosage
Atrial Fibrillation drug therapy
Atrial Fibrillation physiopathology
Benzimidazoles administration & dosage
Blood Coagulation
Blood Group Antigens analysis
Dabigatran
Epistaxis blood
Female
Humans
Immunoglobulins blood
Lupus Erythematosus, Systemic blood
beta-Alanine administration & dosage
beta-Alanine adverse effects
Anemia chemically induced
Antithrombins adverse effects
Benzimidazoles adverse effects
Epistaxis chemically induced
Lupus Erythematosus, Systemic chemically induced
beta-Alanine analogs & derivatives
Subjects
Details
- Language :
- English
- ISSN :
- 1473-5733
- Volume :
- 25
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
- Publication Type :
- Academic Journal
- Accession number :
- 24572762
- Full Text :
- https://doi.org/10.1097/MBC.0000000000000099